Who Paid My Doc
Trufill
Device Neurovascular
PDI 10886704029328
General payments
$2,102,417
Research payments
$4,736,091
Through program year 2025, $2,102,417 in general payments and $4,736,091 in research payments were reported against Trufill (Neurovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $272,802 | 1,572 |
| 2025 | Research | $374,721 | 111 |
| 2024 | General | $662,100 | 1,330 |
| 2024 | Research | $1,086,009 | 253 |
| 2023 | General | $417,016 | 933 |
| 2023 | Research | $1,877,614 | 355 |
| 2022 | General | $384,653 | 1,008 |
| 2022 | Research | $1,177,101 | 175 |
| 2021 | General | $365,846 | 586 |
| 2021 | Research | $220,646 | 27 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 35 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
5,429 general · 921 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.